Yule, Amy M. http://orcid.org/0000-0002-2409-9426
DiSalvo, Maura
Wilens, Timothy E.
Wozniak, Janet
Faraone, Stephen V.
Lyons, Rachael M.
Woodworth, K. Yvonne
Biederman, Joseph
Funding for this research was provided by:
National Institute on Drug Abuse (5K12DA00357-17)
National Institutes of Health (R01HD036317, R01MH050657, R01 DA012945, R01 MH066237-05)
Article History
First Online: 14 March 2020
Compliance with Ethical Standards
:
: Amy Yule received grant support from the Massachusetts General Hospital Louis V. Gerstner III Research Scholar Award from 2014 to 2016. Dr. Yule is currently receiving funding through the American Academy of Child and Adolescent Psychiatry Physician Scientist Program in Substance Abuse 5K12DA000357-17. She was a consultant to the Phoenix House from 2015 to 2017 and is currently a consultant to the Gavin House (clinical services). Timothy Wilens receives or has received grant support from the following sources: NIH(NIDA). Dr. Timothy Wilens is or has been a consultant for: Alcobra, Neurovance/Otsuka, and Ironshore. Dr. Timothy Wilens has a published book: Straight Talk About Psychiatric Medications for Kids (Guilford Press); and co/edited books ADHD in Adults and Children (Cambridge University Press), Massachusetts General Hospital Comprehensive Clinical Psychiatry (Elsevier) and Massachusetts General Hospital Psychopharmacology and Neurotherapeutics (Elsevier. Dr. Wilens is co/owner of a copyrighted diagnostic questionnaire (Before School Functioning Questionnaire). Dr. Wilens is Chief, Division of Child and Adolescent Psychiatry and (Co) Director of the Center for Addiction Medicine at Massachusetts General Hospital. He serves as a clinical consultant to the US National Football League (ERM Associates), U.S. Minor/Major League Baseball; Phoenix/Gavin House and Bay Cove Human Services. Janet Wozniak received research support from PCORI in 2017–2018. She is the author of the book, “Is Your Child Bipolar” published May 2008, Bantam Books. In 2015-2017, her spouse, Dr. John Winkelman, received an honorarium from Otsuka; royalties from Cambridge University Press and UptoDate; consultation fees from Advance Medical, FlexPharma and Merck; and research support from UCB Pharma, NeuroMetrix, and Luitpold. Faraone received income, potential income, travel expenses continuing education support and/or research support from Lundbeck, KenPharm, Rhodes, Arbor, Ironshore, Shire, Akili Interactive Labs, CogCubed, Alcobra, VAYA, Sunovion, Genomind and NeuroLifeSciences in the past year. With his institution, he has US patent US20130217707 A1 for the use of sodium-hydrogen exchange inhibitors in the treatment of ADHD. Joseph Biederman is currently receiving research support from the following sources<i>:</i> AACAP, Feinstein Institute for Medical Research, Food & Drug Administration, Genentech, Headspace Inc., Lundbeck AS, Neurocentria Inc., NIDA, Pfizer Pharmaceuticals, Roche TCRC Inc., Shire Pharmaceuticals Inc., Sunovion Pharmaceuticals Inc., and NIH. Dr. Biederman’s program has received departmental royalties from a copyrighted rating scale used for ADHD diagnoses, paid by Bracket Global, Ingenix, Prophase, Shire, Sunovion, and Theravance; these royalties were paid to the Department of Psychiatry at MGH. In 2019, Dr. Biederman is a consultant for Akili, Jazz Pharma, and Shire. Through MGH corporate licensing, he has a US Patent (#14/027,676) for a non-stimulant treatment for ADHD, a US Patent (#10245271) on a treatment of impaired cognitive flexibility, and a patent pending (#61/233,686) on a method to prevent stimulant abuse. He received honoraria from the MGH Psychiatry Academy for tuition-funded CME courses. In 2018, Dr. Biederman was a consultant for Akili and Shire; he received honoraria from the MGH Psychiatry Academy for tuition-funded CME courses. <i>In 2017, Dr. Biederman</i> received research support from the Department of Defense and PamLab. He was a consultant for Aevi Genomics, Akili, Guidepoint, Ironshore, Medgenics, and Piper Jaffray; he was on the scientific advisory board for Alcobra and Shire; he received honoraria from the MGH Psychiatry Academy for tuition-funded CME courses. Maura Disalvo, Rachael Lyons and K. Yvonne Woodworth declares that they have no conflicts of interest at this time.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Written informed consent was obtained from all individual participants’ parents in this study. Written assent was obtained from all children and adolescents included in this study.